444 related articles for article (PubMed ID: 17158233)
1. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.
Boasso A; Herbeuval JP; Hardy AW; Anderson SA; Dolan MJ; Fuchs D; Shearer GM
Blood; 2007 Apr; 109(8):3351-9. PubMed ID: 17158233
[TBL] [Abstract][Full Text] [Related]
2. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
[TBL] [Abstract][Full Text] [Related]
3. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.
Chen W; Liang X; Peterson AJ; Munn DH; Blazar BR
J Immunol; 2008 Oct; 181(8):5396-404. PubMed ID: 18832696
[TBL] [Abstract][Full Text] [Related]
4. HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation.
Boasso A; Hardy AW; Anderson SA; Dolan MJ; Shearer GM
PLoS One; 2008 Aug; 3(8):e2961. PubMed ID: 18698365
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.
Jenabian MA; Patel M; Kema I; Vyboh K; Kanagaratham C; Radzioch D; Thébault P; Lapointe R; Gilmore N; Ancuta P; Tremblay C; Routy JP
Clin Exp Immunol; 2014 Oct; 178(1):102-11. PubMed ID: 24924152
[TBL] [Abstract][Full Text] [Related]
6. Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy.
Chen J; Xun J; Yang J; Ji Y; Liu L; Qi T; Wang Z; Zhang R; Shen Y; Ponte R; Mehraj V; Routy JP; Lu H
Clin Infect Dis; 2019 Apr; 68(8):1274-1281. PubMed ID: 30107503
[TBL] [Abstract][Full Text] [Related]
7. Differential immunosuppressive effect of indoleamine 2,3-dioxygenase (IDO) on primary human CD4+ and CD8+ T cells.
Forouzandeh F; Jalili RB; Germain M; Duronio V; Ghahary A
Mol Cell Biochem; 2008 Feb; 309(1-2):1-7. PubMed ID: 18008147
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Immunology; 2015 Oct; 146(2):292-300. PubMed ID: 26147366
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.
Hwu P; Du MX; Lapointe R; Do M; Taylor MW; Young HA
J Immunol; 2000 Apr; 164(7):3596-9. PubMed ID: 10725715
[TBL] [Abstract][Full Text] [Related]
11. Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2,3-dioxygenase.
Rytelewski M; Meilleur CE; Yekta MA; Szabo PA; Garg N; Schell TD; Jevnikar AM; Sharif S; Singh B; Haeryfar SM
PLoS One; 2014; 9(2):e90439. PubMed ID: 24587363
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis.
Potula R; Poluektova L; Knipe B; Chrastil J; Heilman D; Dou H; Takikawa O; Munn DH; Gendelman HE; Persidsky Y
Blood; 2005 Oct; 106(7):2382-90. PubMed ID: 15961516
[TBL] [Abstract][Full Text] [Related]
13. Human renal tubular epithelial cells suppress alloreactive T cell proliferation.
Demmers MW; Korevaar SS; Roemeling-van Rhijn M; van den Bosch TP; Hoogduijn MJ; Betjes MG; Weimar W; Baan CC; Rowshani AT
Clin Exp Immunol; 2015 Mar; 179(3):509-19. PubMed ID: 25310899
[TBL] [Abstract][Full Text] [Related]
14. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.
Munn DH; Sharma MD; Mellor AL
J Immunol; 2004 Apr; 172(7):4100-10. PubMed ID: 15034022
[TBL] [Abstract][Full Text] [Related]
15. Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.
Sittig SP; van Beek JJP; Flórez-Grau G; Weiden J; Buschow SI; van der Net MC; van Slooten R; Verbeek MM; Geurtz PBH; Textor J; Figdor CG; de Vries IJM; Schreibelt G
Eur J Immunol; 2021 Jun; 51(6):1494-1504. PubMed ID: 33675038
[TBL] [Abstract][Full Text] [Related]
16. Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure.
Paveglio SA; Allard J; Foster Hodgkins SR; Ather JL; Bevelander M; Campbell JM; Whittaker LeClair LA; McCarthy SM; van der Vliet A; Suratt BT; Boyson JE; Uematsu S; Akira S; Poynter ME
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):11-23. PubMed ID: 20118221
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response.
Suh HS; Zhao ML; Rivieccio M; Choi S; Connolly E; Zhao Y; Takikawa O; Brosnan CF; Lee SC
J Virol; 2007 Sep; 81(18):9838-50. PubMed ID: 17626075
[TBL] [Abstract][Full Text] [Related]
18. NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells.
Tomescu C; Chehimi J; Maino VC; Montaner LJ
J Immunol; 2007 Aug; 179(4):2097-104. PubMed ID: 17675468
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan catabolism in IDO+ plasmacytoid dendritic cells.
Fallarino F; Gizzi S; Mosci P; Grohmann U; Puccetti P
Curr Drug Metab; 2007 Apr; 8(3):209-16. PubMed ID: 17430109
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells.
Eleftheriadis T; Pissas G; Sounidaki M; Tsogka K; Antoniadis N; Antoniadi G; Liakopoulos V; Stefanidis I
Int J Mol Med; 2016 Nov; 38(5):1605-1613. PubMed ID: 27667153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
